Candice Bautista
Resume

Professional Timeline

Download PDF

Experience

Head of Regulatory Affairs

2025 — Present

Valar Labs

  • Lead regulatory strategy for an AI-powered diagnostics platform
  • Built the company's first regulatory function and quality processes
  • Own FDA strategy across SaMD classification and De Novo planning

Senior Regulatory Affairs Lead

2021 — 2025

Artera

  • Led a significant regulatory authorization for a novel AI diagnostic
  • Managed FDA interactions and submission strategy end-to-end
  • Partnered with engineering and clinical teams on AI/ML documentation

Regulatory Affairs Specialist

2017 — 2021

Prior healthcare organization

  • Supported regulatory submissions across diagnostics and oncology
  • Developed early expertise in software as a medical device (SaMD)

Education

Doctor of Pharmacy (PharmD) · University program

Speaking Engagements

DIA Regulatory Affairs Conference — Panel

HealthTech Founders Summit — Talk

RAPS Convergence — Panel

Publications

What 'Predetermined Change Control' Actually Means for Your AI Model

De Novo Is Not a Fallback. Treat It Like a Strategy.

Building a Regulatory Function Before You Think You Need One